SightfileU.S. market data from official filings

Companies › ELDN

ELEDON PHARMACEUTICALS INC (ELDN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001404281 · EDGAR filings · Updated 2026-06-22

ELEDON PHARMACEUTICALS INC (ELDN) has reported institutional ownership of 56.2%, with 121 institutional managers holding positions valued at $131.2M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
56.2%
Institutional managers
121
Reported 13F value
$131.2M
Insider activity
6 trans.
$0 net flat
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ELEDON PHARMACEUTICALS INC has 121 institutional holders and institutional ownership of 56.2%.

Insider activity

Insiders reported 6 transactions (0 buys, 0 sells) across 6 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2025-08-14 (recurring since 2024-08-14) — source filing. The authoritative details are those stated in the filing itself.
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2024-08-19 (recurring since 2020-03-17) — source filing. The authoritative details are those stated in the filing itself.

Related companies

KORRO BIO INC (KRRO) · CVRX INC (CVRX) · NEUMORA THERAPEUTICS INC. (NMRA) · INFUSYSTEM HLDGS INC (INFU) · VOYAGER THERAPEUTICS INC (VYGR) · QUANTERIX CORP (QTRX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.